Jiagen Li

1.1k total citations
49 papers, 850 citations indexed

About

Jiagen Li is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Jiagen Li has authored 49 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomaterials, 19 papers in Biomedical Engineering and 9 papers in Molecular Biology. Recurrent topics in Jiagen Li's work include Nanoparticle-Based Drug Delivery (23 papers), Nanoplatforms for cancer theranostics (14 papers) and Graphene and Nanomaterials Applications (8 papers). Jiagen Li is often cited by papers focused on Nanoparticle-Based Drug Delivery (23 papers), Nanoplatforms for cancer theranostics (14 papers) and Graphene and Nanomaterials Applications (8 papers). Jiagen Li collaborates with scholars based in China, United States and Thailand. Jiagen Li's co-authors include Peng Liu, Xu Jia, Xubo Zhao, Peng Liu, Kun Tian, Tingting Zhou, Mingliang Pei, Pengcheng Du, Xinming Li and Xuefeng Jiang and has published in prestigious journals such as Langmuir, Journal of Cleaner Production and Chemical Engineering Journal.

In The Last Decade

Jiagen Li

46 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiagen Li China 20 390 347 224 203 149 49 850
Xianglin Luo China 18 536 1.4× 347 1.0× 284 1.3× 212 1.0× 177 1.2× 49 1.0k
Ratchapol Jenjob Thailand 12 311 0.8× 274 0.8× 161 0.7× 146 0.7× 233 1.6× 25 792
Tangjian Cheng China 14 365 0.9× 465 1.3× 163 0.7× 278 1.4× 274 1.8× 15 926
Xuefei Zhang China 14 556 1.4× 282 0.8× 160 0.7× 162 0.8× 95 0.6× 32 816
Rouhollah Khodadust Türkiye 12 562 1.4× 379 1.1× 111 0.5× 225 1.1× 228 1.5× 18 951
Xikuang Yao China 14 380 1.0× 379 1.1× 147 0.7× 161 0.8× 211 1.4× 25 783
Linhua Zhang China 14 476 1.2× 280 0.8× 104 0.5× 280 1.4× 126 0.8× 28 814
Shewaye Lakew Mekuria Taiwan 16 339 0.9× 276 0.8× 99 0.4× 213 1.0× 178 1.2× 23 794
Keun Sang Oh South Korea 21 515 1.3× 414 1.2× 123 0.5× 264 1.3× 178 1.2× 32 1.0k
Mazdak Asadian‐Birjand Germany 8 374 1.0× 311 0.9× 127 0.6× 146 0.7× 137 0.9× 10 743

Countries citing papers authored by Jiagen Li

Since Specialization
Citations

This map shows the geographic impact of Jiagen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiagen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiagen Li more than expected).

Fields of papers citing papers by Jiagen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiagen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiagen Li. The network helps show where Jiagen Li may publish in the future.

Co-authorship network of co-authors of Jiagen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiagen Li. A scholar is included among the top collaborators of Jiagen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiagen Li. Jiagen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shihan, Wensheng Liao, Jiagen Li, et al.. (2025). Signal amplification of low concentration doxorubicin detection using the impact electrochemistry of Cu-Co bimetallic nanoparticles with CN vacancies. Microchemical Journal. 209. 112854–112854.
2.
Wei, Xiaoxuan, Hongmin Zhu, Jiagen Li, et al.. (2025). Optimizing photodegradation conditions for efficient removal of gatifloxacin: Balancing degradation efficiency and environmental risk. Journal of Cleaner Production. 512. 145514–145514. 1 indexed citations
3.
Han, Rui, Qinghao Chen, Yan-Cheng Wang, et al.. (2025). IRF8 and CD2 are potential targets of immunotherapy in non-small cell lung cancer. Journal of Thoracic Disease. 17(3). 1169–1184.
4.
Wang, Qihui, Yang Ju, Siqi Yang, et al.. (2025). Dual emission ratiometric fluorescence probe based on N-doped carbon dots and coumarin derivatives for determination of moxifloxacin and copper ion. Analytica Chimica Acta. 1353. 343958–343958. 9 indexed citations
5.
Li, Jiagen, et al.. (2023). Fabrication of pH-responsive co-delivery system for nano selenium and doxorubicin with PEGylated chitosan: Effect of PEGylation. Journal of Drug Delivery Science and Technology. 86. 104706–104706. 5 indexed citations
6.
Mei, Li, et al.. (2023). A SiO2 Hybrid Enzyme-Based Biosensor with Enhanced Electrochemical Stability for Accuracy Detection of Glucose. International Journal of Analytical Chemistry. 2023. 1–8. 4 indexed citations
7.
Deng, Guowei, et al.. (2023). Effect of Preheating Whey Protein Concentrate on the Stability of Purple Sweet Potato Anthocyanins. Polymers. 15(15). 3315–3315. 7 indexed citations
8.
Li, Jiagen & Xuefeng Jiang. (2023). C‐Aryl Glycosylation via Interrupted Pummerer Rearrangement. Chinese Journal of Chemistry. 41(21). 2843–2847. 4 indexed citations
10.
Luo, Xu, et al.. (2023). One-pot synthesis of polymer SiO2-PNPG electrodes as a transducer for the measurement of Pb(ii) in soil. New Journal of Chemistry. 47(29). 13985–13992. 1 indexed citations
11.
Li, Jiagen, et al.. (2023). Chitooligosaccharidegallic acid complexes suppress the denaturation of myofibrillar proteins in peeled shrimp (Litopenaeus vannamei) during frozen storage. International Journal of Food Science & Technology. 58(12). 6399–6410. 3 indexed citations
12.
Li, Jiagen, et al.. (2022). One-pot self-assembly fabrication of chitosan coated hollow sphere for pH/ glutathione dual responsive drug delivery. Colloids and Surfaces B Biointerfaces. 218. 112773–112773. 13 indexed citations
13.
Li, Jiagen, Xinming Li, Mingliang Pei, & Peng Liu. (2020). Acid-labile anhydride-linked doxorubicin-doxorubicin dimer nanoparticles as drug self-delivery system with minimized premature drug leakage and enhanced anti-tumor efficacy. Colloids and Surfaces B Biointerfaces. 192. 111064–111064. 15 indexed citations
14.
Li, Jiagen, Xinming Li, & Peng Liu. (2019). Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release. Colloids and Surfaces B Biointerfaces. 185. 110608–110608. 21 indexed citations
16.
Zhao, Xubo, Kun Tian, Tingting Zhou, et al.. (2018). PEGylated multi-walled carbon nanotubes as versatile vector for tumor-specific intracellular triggered release with enhanced anti-cancer efficiency: Optimization of length and PEGylation degree. Colloids and Surfaces B Biointerfaces. 168. 43–49. 37 indexed citations
18.
Pei, Mingliang, Xu Jia, Xubo Zhao, Jiagen Li, & Peng Liu. (2017). Alginate-based cancer-associated, stimuli-driven and turn-on theranostic prodrug nanogel for cancer detection and treatment. Carbohydrate Polymers. 183. 131–139. 66 indexed citations
19.
Zhao, Xubo, Yuejun Yao, Kun Tian, et al.. (2016). Leakage-free DOX/PEGylated chitosan micelles fabricated via facile one-step assembly for tumor intracellular pH-triggered release. European Journal of Pharmaceutics and Biopharmaceutics. 108. 91–99. 27 indexed citations
20.
Li, Yun, Xiaobin Wu, Jiagen Li, et al.. (2014). Enteral supplementation of alanyl–glutamine attenuates the up-regulation of beta-defensin-2 protein in lung injury induced by intestinal ischemia reperfusion in rats. International Journal of Surgery. 12(11). 1181–1186. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026